§ PHARMACEUTICALS
USD · PharmaceuticalsNKTR
NEKTAR THERAPEUTICS
USDSector · PharmaceuticalsBeta · 1.23
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
185 increased/new, 46 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 9.57 | EPS (TTM) | -8.32 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Fidelity Management | 4.3M | 0.0% | +4155% |
| BVF INC/IL | 2.6M | 5.9% | +64% |
| Two Seas Capital LP | 2.0M | 2.0% | +163% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | n/a | n/a |
| TWO SIGMA INVESTMENTS, LP | 931K | 0.1% | +97% |
| Prosight Management, LP | 735K | 8.7% | +33% |
◇ AC INTELLIGENCE
Top institutional owners for NKTR as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER68.1% · 156 holders
QUALITY / COMPOUNDER17.1% · 9 holders
DEALER / BANK7.1% · 18 holders
PASSIVE / INDEX6.3% · 7 holders
TACTICAL / MACRO4.0% · 5 holders
SYSTEMATIC / QUANT1.5% · 8 holders
INCOME / DEFENSIVE0.3% · 6 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for NKTR in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention NKTR yet.